1-12 of 12
Edward R Scheffer Cliff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Global Access to Chimeric Antigen Receptor (CAR) T-Cell Therapies: Health Technology Assessment (HTA) of CAR T in G7 Countries and Australia

Alex Y Ge, William B Feldman, Martin F Kaiser, Kai Rejeski, Gloria Iacoboni, Michael J Dickinson, Aaron S Kesselheim, Edward R Scheffer Cliff
Journal: Blood
Blood (2024) 144 (Supplement 1): 3659.
https://doi.org/10.1182/blood-2024-208943
Published: 2024
Journal Articles

The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain
Journal: Blood
Blood (2024) 144 (Supplement 1): 652.
https://doi.org/10.1182/blood-2024-202153
Published: 2024
Journal Articles

Venetoclax in Patients with Multiple Myeloma with or without t(11;14): A Real-World Analysis

Edward R Scheffer Cliff, Martin F Kaiser, Douglas W. Sborov, Rafael Fonseca, Ghulam Rehman Mohyuddin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3792.6.
https://doi.org/10.1182/blood-2024-207365
Published: 2024
Journal Articles

Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey

Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Katherine Berger, Ryan Winborg, Mason S. Barnes, Jorge Arturo Hurtado Martinez, Jay R. Hydren, Douglas W Sborov, Amandeep Godara, Brian McClune, Christopher Booth, Edward R Scheffer Cliff
Journal: Blood
Blood (2024) 144 (Supplement 1): 2281.
https://doi.org/10.1182/blood-2024-208803
Published: 2024
Journal Articles

Using Circulating Tumor DNA to Spare Patients with DLBCL Unnecessary Treatment and Cost: A Model-Based Analysis

Edward R Scheffer Cliff, David A Russler-Germain, Amar H. Kelkar
Journal: Blood
Blood (2024) 144 (Supplement 1): 3657.
https://doi.org/10.1182/blood-2024-207430
Published: 2024
Journal Articles

Secondary Hematologic Malignancies in Patients Following Chimeric Antigen Receptor T-Cell Therapy: Aggregated Clinical Trial Data from 1542 Patients

Edward R Scheffer Cliff, Penelope Lafeuille, Sheila Diamond, Jacob Aptekar, David A Russler-Germain, Kai Rejeski, Aaron S Kesselheim
Journal: Blood
Blood (2024) 144 (Supplement 1): 2077.
https://doi.org/10.1182/blood-2024-203979
Published: 2024
Journal Articles

Cell-of-origin effect of polatuzumab vedotin in diffuse large B-cell lymphoma: no ordinary subgroup analysis

Clinical Trials & Observations
David A. Russler-Germain, Edward R. Scheffer Cliff, Nancy L. Bartlett
Journal: Blood
Blood (2023) 142 (25): 2216–2219.
https://doi.org/10.1182/blood.2023022048
Published: 2023
Journal Articles

Trends in Medicare Spending on Multiple Myeloma Drugs, 2013 to 2021

Edward R Scheffer Cliff, Mark McGuire, Ghulam Rehman Mohyuddin, Aaron Seth Kesselheim, William B Feldman
Journal: Blood
Blood (2023) 142 (Supplement 1): 5086.
https://doi.org/10.1182/blood-2023-190372
Published: 2023
Journal Articles

Risk Stratification Models Overestimate Progression Risk in Contemporary Patients with Smoldering Multiple Myeloma (SMM)

George Mellgard, Molly Gilligan, Edward R Scheffer Cliff, Divaya Bhutani, Ghulam Rehman Mohyuddin, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood
Blood (2023) 142 (Supplement 1): 4768.
https://doi.org/10.1182/blood-2023-174908
Published: 2023
Journal Articles

Prevalence of Exclusion Criteria in Multiple Myeloma Randomized Controlled Trials: A Systematic Review

Joshua White, Sara Zhukovsky, Edward R Scheffer Cliff, Rajshekhar Chakraborty, Luciano Costa, Oliver Van Oekelen, Doug Sborov, Ghulam Rehman Mohyuddin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2402.
https://doi.org/10.1182/blood-2023-185175
Published: 2023
Journal Articles

Assessing the Impact of Blood Cancer Talks , a Novel ‘how I Treat’ Style Podcast on Hematologic Malignancies: A Survey-Based Analysis

Rajshekhar Chakraborty, Edward R Scheffer Cliff, Ashwin Kishtagari
Journal: Blood
Blood (2023) 142 (Supplement 1): 7270.
https://doi.org/10.1182/blood-2023-184594
Published: 2023
Journal Articles

Pola-R-CHP for DLBCL: cost-effective at first glance

Edward R. Scheffer Cliff, Ankur Pandya
Journal: Blood
Blood (2022) 140 (25): 2654–2655.
https://doi.org/10.1182/blood.2022017342
Published: 2022